aprinoia Venture Capital
1 known investors
APRINOIA develops diagnostic tools and therapeutics targeting protein aggregates implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's. The company employs precision medicine approaches to identify disease biomarkers and develop small and large molecule treatments to slow disease progression.
AI & Machine LearningBiotechMedical Devices